Sense Neuro Diagnostics news
- Clinical trial underway at five US hospital sites to evaluate Sense’s novel, non-invasive brain scanner to monitor intracranial hemorrhage in acute hospital setting
- Drug Controller General of India (DCGI) and Health Canada grant permission to conduct clinical trial at multiple sites in India and Canada
- Current standard of care lacks a means to monitor brain injury continuously, non-invasively, in real time, between CT scans
Sense Neuro Diagnostics, founded in 2014 by four University of Cincinnati physicians, said the $2.43 million, 18-month award from the U.S. Department of Defense will accelerate development of a new rapid, noninvasive brain scanner that can detect and continuously monitor traumatic brain injury in a battlefield or field environment.
TBI, for short, is a signature wound of recent wars. There have been roughly 420,000 documented incidents of service members sustaining at least one TBI in
More than 400,000 military personnel have suffered at least one traumatic brain injury in the last two decades. Long-term consequences for patients may have been better if doctors could more quickly have diagnosed the situation and treated it.
Now there appears to be a solution and it involves the Norwood company Sense Neuro Diagnostics.